Open AccessComprehensive evaluation of cardiovascular efficacy and safety outcomes of SGLT2 inhibitors in high risk patients of cardiovascular disease: systematic review and meta-analysis
Author(s) -
Mukul Bhattarai,
Mohsin Salih,
Manjari Regmi,
Mohammad AlAkchar,
Cameron Koester,
Abdisamad M. Ibrahim,
Priyanka Parajuli,
Odalys Lara Garcia,
Bishal Bhandari,
Anis Rehman,
Momin Siddique
Publication year - 2020
Publication title -
cardiovascular endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.498
H-Index - 8
ISSN - 2574-0954
DOI - 10.1097/xce.0000000000000229
Subject(s) - medicine , odds ratio , heart failure , myocardial infarction , confidence interval , placebo , meta analysis , adverse effect , alternative medicine , pathology
To demonstrate a magnitude of the cardiovascular benefits, concomitantly analyzing the safety outcomes of sodium-glucose cotransporter 2 inhibitor (SGLT2-I) comprehensively, as a class effect in a larger sample size combined from recent randomized control trials.